News and Comments


  Monday, October 08, 2012

In an effort to find additional small biotech firms with solid scientific fundamentals and products that promise reaching beyond the limiting horizon, we pinpointed ten to date. We picked them from among one hundred biotech firms that have little, or none of the properties that make out   super achievers. We decided to go on and start with a company called ChemoCentryx (CCXI). Our selection was not based on priority, preference, or any other reason that might insinuate advantages over the other nine firms we picked for comprehensive reviewing. It was rather based on curiosity triggered by a recent announcement by the firm of preclinical results of a small molecule oral drug CCX872 aimed at blocking the chemokine receptor CCR2 for the treatment of diabetes nephropathy.  More...

Recent Postings



Trastuzumab-DM1 Intrexon (XON) Agenus (AGEN Incyte (INCY) NANTKWEST (NK) Biogen Idec (BIIB) KERYX (KERX) Abbott Laboratories (ABT) Rapamune OSI (OSIP) Ridaforolimus Intermune (ITMN) Sanofi (SNY) AERIE PHARMACEUTICALS Theravance (THRX) Endometrial Cancer JUNO (JUNO) ARCA (ABIO) Human Longevity (HLI) INNOVIVA (INVA) ADVENTRIX (ANX) Theravance Bio Pharma (TBPH) ARGOS (ARGS) Idenix (IDIX) Ionis (IONS) Seattle Genetics (SGEN) Galena (GALE) Herceptin Mirati Therapeutics (MRTX) Jazz Pharmaceuticals (JAZZ) Inovio (INO) ACADIA (ACAD) CompuGen (CGEN) Zerenex RenenxBio (RGNX) Array Pharmaceuticals (ARRY) BIOMARIN (BMRN) SERES THERAPEUTICS (MCRB) Biocryst (BCRX) Alder Biopharmaceuticals (ALDR) Benlysta (belimumab) Genentech AGOS (ARGS) IDERA (IDRA) Gilead (GILD) ABBVIE (ABBV) Illumina (ILMN) REGULUS (RGLS) Roche (ROCHE) Agenus (AGEN) Exelixis (EXEL) ZALTRAP™ Sarepta (SRPT) Merck (MRK) Global Cell Therapeutics (GBT) Regeneron (REGN) Amgen (AMGN) Multiple Myeloma Anadys (ANDS) galapagos (GLPG) HALOZYME (HALO) SYNTA (SNTA) Vertex (VRTX) Prosensa (RNA) Sequenom (SQNM) TOKAI (TKAOI) Alnylam (ALNY) Anacor (ANAC) ISIS (ISIS) Telaprevir GUARDIAN HEALTH Xoma (XOMA) Valeant Pharmaceuticals International (VRX) C4 Therapeutics Editas (EDIT) Intercept (ICPT) Prolor Biotech (PBTH) Tysabri Vitae Pharmaceuticals (VTAE) SUNESIS PHARMACEUTICALS (SNSS) Bristol-Myers Squibb (BMY) Ziofpharm (ZIOP) VANDA (VNDA) Elan (ELN) Auspex (ASPX) Velcade (bortezomib) Spike Therapeutics (ONCE) Roche (RHHBY) Pluristem (PSTI) Sanofi (SNA) KITE (KITE) Onyx (ONXX) Ariad (ARIA) PTC Therapeutics (PTCT) Sanofi-Aventis (SAN) NEKTAR (NKTR)) Dendreon (DNDN) ImmunoGen (IMGN) Revlimid (lenolidamide) GlaxoSmithKline (GSK) Micromet (MITI) Cytokinetics (CYTK) Human Genome Sciences (HGSI) Aimmune Therapeutics (AIMT) Sangamo (SGMO) Dynavax (DVAX)